Communiqués Scorpius Holdings, Inc.

Actions

SCPX

US42237K5083

Sociétés holdings

Marché Fermé - OTC Markets Autres places de cotation 18:26:17 23/06/2026			Varia. 5j.	Varia. 1 janv.
0,001200 ^USD	-45,45%		+9,09%	+500,00%

17/02	Scorpius Holdings, Inc. publie ses résultats financiers pour le troisième trimestre et les neuf mois clos le 30 septembre 2025	CI
12/01	Scorpius Holdings, Inc. publie ses résultats financiers pour le deuxième trimestre et le semestre clos le 30 juin 2025	CI

Communiqués

12/01	Scorpius : Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)	PU
14/11/24	Scorpius : Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability Form 8 K	PU
22/10/24	Scorpius Holdings Announces Partnership with U.S. Biotech Company	AQ
02/10/24	Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats	AQ
30/09/24	Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities	AQ
12/09/24	Scorpius Holdings Commends the U.S. House of Representatives’ Passage of the BIOSECURE Act	AQ
26/08/24	Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow	AQ
19/08/24	Scorpius Holdings, Inc. Announces Pricing of Public Offering	AQ
16/08/24	Scorpius Holdings, Inc. Announces Pricing of Public Offering	AQ
09/08/24	Scorpius Holdings, Inc. Provides Update on its Previously Announced Public Offering	AQ
07/08/24	Scorpius Holdings Weighted-Average Pipeline Surpasses $100 Million in Business Develop Opportunities Across Both Manufacturing Client and Government Sectors	AQ
18/07/24	Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility	GL
17/07/24	Scorpius Holdings Announces Reverse Stock Split	GL
17/06/24	Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal	GL
03/06/24	Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing	GL
29/05/24	Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024	GL
20/05/24	Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility	GL
20/05/24	Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility	AQ
16/05/24	Scorpius Holdings, Inc. Announces Closing of Public Offering	GL
16/05/24	Scorpius Holdings Commends Congress on Bipartisan Legislative Action Aimed at Bolstering U.S. Biomanufacturing	AQ
16/05/24	Scorpius Holdings Commends Congress on Bipartisan Legislative Action Aimed at Bolstering U.S. Biomanufacturing	GL
15/05/24	Scorpius Holdings Achieves Major Milestone with cGMP Facility Validation for Microbial Manufacturing	AQ
15/05/24	Scorpius Holdings Achieves Major Milestone with cGMP Facility Validation for Microbial Manufacturing	GL
14/05/24	Scorpius Holdings, Inc. Announces Pricing of Public Offering	GL
13/05/24	Scorpius : Results of Operations and Financial Condition - Form 8-K	PU